NO903509L - Farmasoeytiske materialer. - Google Patents

Farmasoeytiske materialer.

Info

Publication number
NO903509L
NO903509L NO90903509A NO903509A NO903509L NO 903509 L NO903509 L NO 903509L NO 90903509 A NO90903509 A NO 90903509A NO 903509 A NO903509 A NO 903509A NO 903509 L NO903509 L NO 903509L
Authority
NO
Norway
Prior art keywords
gamma
interferons
linolenic acid
pharmasoeytic
materials
Prior art date
Application number
NO90903509A
Other languages
English (en)
Other versions
NO903509D0 (no
Inventor
David Frederick Horrobin
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of NO903509D0 publication Critical patent/NO903509D0/no
Publication of NO903509L publication Critical patent/NO903509L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Anvendelse av en eller flere av gamma-linolensyre, dihomo- gamma-linolensyre og arachidonsyre for fremstilling av et medikament for anvendelse til forsterkning av anti-virus-, anti- kreft- eller anti-inflammatoriske effekter av interferoner, hvor medikamentet inneholder, eller er for anvendelse med, et medikament som inneholder ett eller flere interferoner, når det ikke bare anvendes for forsterkning av effekten av endogene interferoner.
NO90903509A 1989-08-10 1990-08-09 Farmasoeytiske materialer. NO903509L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918294A GB8918294D0 (en) 1989-08-10 1989-08-10 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO903509D0 NO903509D0 (no) 1990-08-09
NO903509L true NO903509L (no) 1991-02-11

Family

ID=10661451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903509A NO903509L (no) 1989-08-10 1990-08-09 Farmasoeytiske materialer.

Country Status (15)

Country Link
US (1) US5580556A (no)
EP (2) EP0416743B1 (no)
AT (1) ATE123948T1 (no)
AU (1) AU633603B2 (no)
CA (1) CA2022608A1 (no)
DE (1) DE69020267T2 (no)
DK (1) DK0416743T3 (no)
ES (1) ES2073533T3 (no)
GB (1) GB8918294D0 (no)
GR (1) GR3016980T3 (no)
HK (1) HK53496A (no)
IE (1) IE67773B1 (no)
NO (1) NO903509L (no)
NZ (1) NZ234786A (no)
ZA (1) ZA906187B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
WO1997044026A1 (en) * 1996-05-22 1997-11-27 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
ATE556706T1 (de) 2001-03-23 2012-05-15 Luitpold Pharm Inc Fettalkohol-arzneimittel-konjugate
WO2002076402A2 (en) 2001-03-23 2002-10-03 Protarga, Inc. Fatty amine drug conjugates
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2013110077A1 (en) 2012-01-19 2013-07-25 Hybrid Medical, Llc Topical therapeutic formulations
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
CA2953633A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
EP0106571A3 (en) * 1982-09-22 1984-07-25 Sentrachem Limited Prophylactic substance or composition
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
IE63225B1 (en) * 1988-09-13 1995-04-05 Efamol Holdings Use of fatty acids in the treatment of myalgic encephalomyelitis

Also Published As

Publication number Publication date
EP0678299A2 (en) 1995-10-25
EP0416743A1 (en) 1991-03-13
IE67773B1 (en) 1996-04-17
EP0416743B1 (en) 1995-06-21
HK53496A (en) 1996-04-03
DK0416743T3 (da) 1995-08-14
GR3016980T3 (en) 1995-11-30
DE69020267D1 (de) 1995-07-27
ZA906187B (en) 1991-06-26
DE69020267T2 (de) 1996-01-25
AU6017890A (en) 1991-02-14
GB8918294D0 (en) 1989-09-20
NZ234786A (en) 1997-06-24
US5580556A (en) 1996-12-03
AU633603B2 (en) 1993-02-04
CA2022608A1 (en) 1991-02-11
ES2073533T3 (es) 1995-08-16
IE902774A1 (en) 1991-02-27
NO903509D0 (no) 1990-08-09
ATE123948T1 (de) 1995-07-15
EP0678299A3 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
NO903509L (no) Farmasoeytiske materialer.
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
ATE80303T1 (de) Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen.
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
ATE413885T1 (de) Getrocknete blutfaktorzusammensetzung mit trehalose
BE847515A (fr) Elements stratifies a surface plane et a pouvoir absorbant, notamment pour la fabrication d'articles d'hygiene
ATE12732T1 (de) Pharmazeutische und diaetetische zusammensetzungen.
ES2107622T3 (es) Medicamento para el tratamiento de la distrofia vulvar o la sequedad vaginal.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
DE3770278D1 (de) Harzartige zusammensetzung, die ein acrylharz enthaelt mit langen gruppen mit karboxylgruppen am ende und deren herstellung.
MX14512A (es) Composicion fotopolimerizable y articulo que comprende la composicion.
DK0551729T3 (da) gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
FR1342178A (fr) Enduit de matière céramique et de verre spécial lubrifiant sous forme d'une pellicule solide
FI853231L (fi) Anordning foer foerdelning av styckealster i matningsmekanismer.
DE3881916D1 (de) Kamerageraet mit reduzierung der last des motorischen filmtransports waehrend des filmladens.
ES491452A0 (es) Perfeccionamientos en la fabricacion de cintas transportado-ras
IT8023243A0 (it) Procedimento per la realizzazione di manufatti in lamiere metalliche e plastici rinforzati e manufatti realizzati con tale procedimento.
DE68901265D1 (de) Triglycerides und nahrungszusammensetzung die diese enthaelt.
ES267557Y (es) "disposicion perfeccionada para el embalaje de pies artisticos y similares".
DE68901264D1 (de) Triglycerides und zusammensetzung die diese enthaelt.